24 March 2018
News and Views
Links and Services
Rectal indomethacin reduces pancreatitis in high- and low-risk patients undergoing endoscopic retrograde cholangiopancreatography, reports the latest issue of Gastroenterology.
Rectal indomethacin reduces the risk of pancreatitis after endoscopic retrograde cholangiopancrea
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors